跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Rexithro - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Rexithro
Approved
STANDARD
Rexithro
Stallion Laboratories Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
40bb7b303cc97d43
Company
Stallion Laboratories Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
40bb7b303cc97d43
Drug Approval Philippines Name
Rexithro
Product Name
Rexithro
Registration Number
DRP-3322-05
Brand Name
Rexithro
Generic Name
Azithromycin (as dihydrate)
Dosage Form
Powder For Suspension
Dosage Strength
200 mg/5 mL
Manufacturer
Stallion Laboratories Pvt. Ltd.
Importer
Ambica International Corporation
Distributor
Rexmed Pharmaceutical Sales
Issuance Date
27 March 2024
Expiry Date
08 July 2029
Pharmacologic Category
Antibacterial (Macrolide)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
40bb7b303cc97d43
Type
Standard
Back to Philippines FDA Approvals